November 30, 2021 18:32 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
No Mamata-Uddhav meeting in Mumbai owing to Maharashtra CM's health condition | BSP will fight UP polls alone: Mayawati | Centre asks states and UTs to ramp up COVID-19 testing amid Omicron scare | Fuel prices remain unchanged | Opposition MPs' suspension won't be revoked: Rajya Sabha chairman Venkaiah Naidu
Jammu and Kashmir allocated 100 more vials of Amphotericin-B to treat Black Fungus  Jammu and Kashmir

Jammu and Kashmir allocated 100 more vials of Amphotericin-B to treat Black Fungus 

India Blooms News Service | @indiablooms | 29 May 2021, 03:45 pm

Srinagar: Black Fungus patients undergoing treatment at Government ENT Hospital, Koti inHyderabad (ANI Photo)Amid black fungus cases being reported in Jammu and Kashmir, the central governmenthas allocated 100 more vials of Amphotericin-B for treating mucormycosis to the UT. 

Earlier, J&K had been allocated 50 such vials on May 26. 

The central government on May 27 allocated 80,000 vials of Amphotericin-B to all thestates and UTs, a day earlier it had allocated 29,250 such vials.J&K has reported ten cases of black fungus so far. 

While the disease has caused twodeaths, remaining eight patients are undergoing treatment at government hospitals in theUT.According to doctors, Amphotericin-B is used to treat mucormycosis, also known asBlack Fungus, which damages the nose, eyes, sinuses, and sometimes even the brain. 

As per government data on Wednesday, India has recorded 11,717 cases of “blackfungus” or mucormycosis so far with Gujarat, Maharashtra, Andhra Pradesh, MadhyaPradesh and Telangana topping the list. 

Maharashtra has reported 2,770 black funguscases, Gujarat 2,859, Andhra Pradesh 768, Madhya Pradesh 752, and Telangana 744. 

Mucormycosis primarily affects people recovering from COVID-19 and has beensteadily rising across the country. Several states and UT of J&K as well have declaredblack fungus an epidemic.Its treatment requires a multidisciplinary approach from experts consisting eye andgeneral surgeons, neu